Megan Brady, PA
Physician Assistant · Round Rock, TXNPI 1043991920
Payments from drug & device makers
Across 356 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$912
- Lundbeck LLC$680
- Neurocrine Biosciences, Inc.$679
- Alkermes, Inc.$654
- AbbVie$521
- Axsome Therapeutics, Inc.$472
- plus $3K from 18 others
What the payments were for
- Food & beverage$6,658100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 44 | $912 |
| Lundbeck LLC | 34 | $680 |
| Neurocrine Biosciences, Inc. | 27 | $679 |
| Alkermes, Inc. | 40 | $654 |
| AbbVie | 28 | $521 |
| Axsome Therapeutics, Inc. | 29 | $472 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $452 |
| Corium, LLC | 21 | $415 |
| Bausch Health US, LLC | 15 | $299 |
| Teva Pharmaceuticals USA, Inc. | 15 | $293 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $244 |
| Vanda Pharmaceuticals Inc. | 16 | $204 |
| Biogen | 6 | $133 |
| Ironshore Pharmaceuticals Inc. | 7 | $120 |
| Noven Therapeutics, LLC | 6 | $112 |
| Tris Pharma Inc | 4 | $83 |
| E.r. Squibb & Sons, L.L.C. | 4 | $72 |
| Idorsia Pharmaceuticals US Inc | 4 | $69 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Johnson & Johnson | 2 | $42 |
| OWP Pharmaceuticals, Inc. | 2 | $36 |
| Vertical Pharmaceuticals, LLC | 2 | $36 |
| Avion Pharmaceuticals | 1 | $26 |
How this compares
$6,658 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 27 | $1,459 |
| Duloxetine Hcl | 29 | $792 |
| Bupropion XlBupropion Hcl | 47 | $706 |
| Quetiapine Fumarate | 12 | $420 |
| Escitalopram Oxalate | 30 | $341 |
| Trazodone Hcl | 21 | $278 |
| Alprazolam | 25 | $275 |
| Buspirone Hcl | 17 | $230 |
| Gabapentin | 13 | $189 |
| Fluoxetine Hcl | 17 | $105 |
| Lamotrigine | 11 | $102 |
| Clonazepam | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Round Rock
- Dustin FontenotRound Rock$47K
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.